We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Study of Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01271790
Recruitment Status : Completed
First Posted : January 7, 2011
Last Update Posted : February 6, 2014
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2013
  Study Completion Date : September 2013
  Certification or Request for Extension to Delay Results Submission: November 27, 2013